{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T01:26:15Z","timestamp":1648689975982},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1987,2,1]],"date-time":"1987-02-01T00:00:00Z","timestamp":539136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutisch Weekblad Scientific Edition"],"published-print":{"date-parts":[[1987,2]]},"DOI":"10.1007\/bf02075259","type":"journal-article","created":{"date-parts":[[2005,8,14]],"date-time":"2005-08-14T11:58:19Z","timestamp":1124020699000},"page":"S45-S47","source":"Crossref","is-referenced-by-count":3,"title":["Ciprofloxacin for infection prevention in patients with acute leukemia"],"prefix":"10.1007","volume":"9","author":[{"given":"M.","family":"Rozenberg-Arska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. W.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02075259_CR1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/infdis\/147.4.611","volume":"147","author":"LS Young","year":"1983","unstructured":"Young LS. Antimicrobial prophylaxis against infection in neutropenic patients (Editorial). J Infect Dis 1983;147:611\u20134.","journal-title":"J Infect Dis"},{"key":"BF02075259_CR2","first-page":"223","volume":"67","author":"PA Pizzo","year":"1983","unstructured":"Pizzo PA, Schimpff SC. Strategics for the prevention of infections in the myelosuppressed or immunosuppressed cancer patients. Cancer Treat Rep 1983;67:223\u20134.","journal-title":"Cancer Treat Rep"},{"key":"BF02075259_CR3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.7326\/0003-4819-77-5-707","volume":"77","author":"SC Schimpff","year":"1972","unstructured":"Schimpff SC, Young VM, Greene WH, Vermeulen GD, Moody MR, Wiernik PH. Origin of infection in acute nonlymphocytic leukemia: Significance of hospital acquisition of potential pathogens. Ann Intern Med 1972;77:707\u201314.","journal-title":"Ann Intern Med"},{"key":"BF02075259_CR4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1017\/S002217240002341X","volume":"72","author":"D Waaij Van der","year":"1974","unstructured":"Van der Waaij D, Berghuis-de Vries JM. Selective elimination of Enterobacteriaceae species from the digestive tract in mice and monkeys. J Hyg (Camb) 1974;72:205\u201311.","journal-title":"J Hyg (Camb)"},{"key":"BF02075259_CR5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0014-2964(80)90140-1","volume":"16","author":"DT Sleijfer","year":"1980","unstructured":"Sleijfer DT, Mulder NH, De Vries-Hospers HG, Fidler V, Nieweg HO, Van der Waaij D, Van Saene HKF. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer 1980;16:859\u201369.","journal-title":"Eur J Cancer"},{"key":"BF02075259_CR6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-95-5-555","volume":"95","author":"AW Dekker","year":"1981","unstructured":"Dekker AW, Rozenberg-Arska M, Sixma JJ, Verhoef J. Prevention of infection by trimethoprim\/sulfamethoxazoleplus amphotericin B in patients with acute nonlymphocytic leukaemia. Ann Intern Med 1981;95:555\u20139.","journal-title":"Ann Intern Med"},{"key":"BF02075259_CR7","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/infdis\/147.4.624","volume":"147","author":"JC Wade","year":"1983","unstructured":"Wade JC, De Jongh CA, Newman KA, Crowley J, Wiernik PH, Schimpff SC. Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim\/sulfamethoxazole vs. nalidixic acid. J Infect Dis 1983;147:624\u201334.","journal-title":"J Infect Dis"},{"key":"BF02075259_CR8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF01641298","volume":"11","author":"M Rozenberg-Arska","year":"1983","unstructured":"Rozenberg-Arska M, Dekker AW, Verhoef J. Colistin and trimethoprim\/sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease of emergence of resistant bacteria. Infection 1983;11:167\u20139.","journal-title":"Infection"},{"key":"BF02075259_CR9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF02001575","volume":"2","author":"A Bauernfeind","year":"1983","unstructured":"Bauernfeind A, Petermuller C. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. Eur J Clin Microbiol 1983;2:111\u20135.","journal-title":"Eur J Clin Microbiol"},{"key":"BF02075259_CR10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1128\/AAC.23.4.559","volume":"23","author":"R Wise","year":"1983","unstructured":"Wise R, Andrews JM, Edwards LJ. In vitro activity of BAY 09867, a new quinolone derivative, compared with those of other antimicrobial agents. Antimicrob Agents Chemother 1983:23:599\u201364.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF02075259_CR11","doi-asserted-by":"crossref","unstructured":"The quinolones (Editorial). Lancet 1984; 1:24\u20135.","DOI":"10.1016\/0304-3835(84)90072-7"},{"key":"BF02075259_CR12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1128\/AAC.24.5.784","volume":"24","author":"B Crump","year":"1983","unstructured":"Crump B, Wise R, Dent J. Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrob Agents Chemother 1983:24:784\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF02075259_CR13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/infdis\/152.1.104","volume":"152","author":"M Rozenberg-Arska","year":"1985","unstructured":"Rozenberg-Arska M, Dekker AW, Verhoef J. Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on faecal flora. J Infect Dis 1985;152:104\u20137.","journal-title":"J Infect Dis"},{"key":"BF02075259_CR14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-106-1-7","volume":"106","author":"AW Dekker","year":"1987","unstructured":"Dekker AW, Rozenberg-Arska M, Verhoef J. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Ann Intern Med 1987;106:7\u201312.","journal-title":"Ann Intern Med"},{"key":"BF02075259_CR15","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/0002-9343(86)90633-9","volume":"80","author":"DJ Winston","year":"1986","unstructured":"Winston DJ, Ho WG, Nakao SL, Gale RP, Champlin RE. Norfloxacin versus vancomycin\/polymyxin for prevention of infections in granulocytopenic patients. Am J Med 1986;80:884\u201390.","journal-title":"Am J Med"},{"key":"BF02075259_CR16","volume-title":"Double-blind randomized trial of oral prophylactic norfloxacin on infection in acute leukemia (Abstract 149)","author":"JE Karp","year":"1985","unstructured":"Karp JE, Hendricksen C, Redden T, Bartlett J. Double-blind randomized trial of oral prophylactic norfloxacin on infection in acute leukemia (Abstract 149). In: Proceedings of the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington D.C.: American Society for Microbiology, 1985."},{"key":"BF02075259_CR17","volume-title":"Norfloxacin (N) versus trimethoprim\/sulfamethoxazole (T\/S) for infection prevention in patients (pts) with acute leukemia (AL) (Abstract 150)","author":"EJ Bow","year":"1985","unstructured":"Bow EJ, Louie TJ, Rayner E, Pitsanuk J. Norfloxacin (N) versus trimethoprim\/sulfamethoxazole (T\/S) for infection prevention in patients (pts) with acute leukemia (AL) (Abstract 150). In: Proceedings of the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington D.C.: American Society for Microbiology, 1985."}],"container-title":["Pharmaceutisch Weekblad Scientific Edition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02075259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02075259\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02075259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:53:13Z","timestamp":1586393593000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02075259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,2]]},"references-count":17,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1987,2]]}},"alternative-id":["BF02075259"],"URL":"https:\/\/doi.org\/10.1007\/bf02075259","relation":{},"ISSN":["0167-6555","1573-739X"],"issn-type":[{"value":"0167-6555","type":"print"},{"value":"1573-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,2]]}}}